New daily diabetes pill that helps with weight loss launches in UK pharmacies
Orforglipron, known as Foundayo, is a weight loss pill developed by the US pharmaceutical firm Eli Lilly. Photograph: Michael Siluk/AlamyView image in fullscreenOrforglipron, known as Foundayo, is a weight loss pill developed by the US pharmaceutical firm Eli Lilly. The UK is the first country in Europe to approve it, after approving another weight-loss pill in June.“The UK is the first country in Europe where Foundayo is now available,” said Khalil Asmar, the vice-president of cardiometabolic health at Lilly Northern Europe.
- ▪Orforglipron, known as Foundayo, is a weight loss pill developed by the US pharmaceutical firm Eli Lilly.
- ▪Photograph: Michael Siluk/AlamyView image in fullscreenOrforglipron, known as Foundayo, is a weight loss pill developed by the US pharmaceutical firm Eli Lilly.
- ▪The UK is the first country in Europe to approve it, after approving another weight-loss pill in June.“The UK is the first country in Europe where Foundayo is now available,” said Khalil Asmar, the vice-president of cardiometabolic health a
The Guardian — World publishes from United Kingdom and files mainly under world. We currently carry 3,089 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | World news | The Guardian |
| Canonical URL | https://www.theguardian.com/society/2026/aug/24/daily-diabetes-pill-foundayo-weight-loss-uk-pharmacies |
| Publication time | Mon, 24 Aug 2026 05:01:52 GMT |
| Retrieval time | 2026-08-24T05:27:25.292Z |
| Last seen | 2026-08-24T05:27:25.292Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | None |
| Cluster logic | Not yet clustered, or no peer story found in the clustering window. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Orforglipron, known as Foundayo, is a weight loss pill developed by the US pharmaceutical firm Eli Lilly. Photograph: Michael Siluk/AlamyView image in fullscreenOrforglipron, known as Foundayo, is a weight loss pill developed by the US pharmaceutical firm Eli Lilly. Photograph: Michael Siluk/AlamyHealthNew daily diabetes pill that helps with weight loss launches in UK pharmaciesFoundayo will be available on private prescription, with pharmacists warning of counterfeit GLP-1 problemHannah Devlin Science correspondentMon 24 Aug 2026 01.01 EDTSharePrefer the Guardian on GoogleA new daily pill that treats diabetes and helps with weight loss will be available in UK pharmacies from Monday.Pharmacists said the move would be welcome for people who cannot use weight-loss jabs, but also issued a…
Excerpt limited to ~120 words for fair-use compliance. The full article is at World news | The Guardian.
Discussion
0 commentsMore from World news | The Guardian
